高海拔相关疾病

Roach RC, Bärtsch P, Oelz O, et al; Lake Louise Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and molecular medicine. Burlington, VT: Charles S. Houston, 1993:272-274.

Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med. 2014;25(suppl):S4-S14.

• 全文
• 摘要

Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide for the prevention of acute mountain sickness - a systematic review and meta-analysis. J Travel Med. 2012;19:298-307.

• 全文
• 摘要

1.  Roach RC, Bärtsch P, Oelz O, et al; Lake Louise Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and molecular medicine. Burlington, VT: Charles S. Houston, 1993:272-274.

2.  Wright AD, Brearley SP, Imray CH. High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high altitude cerebral and pulmonary oedema. Expert Opin Pharmacother. 2008;9:1-9.

• 摘要

3.  Hultgren H. High altitude medicine. Stamford, CT: Hultgren Publications; 2001.

4.  Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993;118:587-592.

• 摘要

5.  Hackett PH, Roach RC. High altitude illness. New Engl J Med. 2001;345:107-114.

• 摘要

6.  Maggiorini M, Bärtsch P, Walter M, et al. Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 1990;301:853-855.

• 全文
• 摘要

7.  Vardy J, Vardy J, Judge K, et al. Acute mountain sickness and ascent rate in trekkers above 2500m in the Nepali Himalaya. Aviat Space Environ Med. 2006;77:742-744.

• 摘要

8.  Murdoch DR. Altitude illness among tourists flying to 3740 meters elevation in the Nepal Himalayas. J Trav Med. 1995;2:255-256.

• 全文
• 摘要

9.  Purkayastha SS, Ray US, Arora BS, et al. Acclimatization at high altitude in gradual and acute induction. J Appl Physiol. 1995;79:487-492.

• 摘要

10.  Basnyat B, Subedi D, Sleggs J, et al. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high altitude cerebral edema at a sacred lake at 4300m in the Nepal Himalayas. Wilderness Environ Med. 2000;11:89-93.

• 摘要

11.  Gabry AL, Ledoux X, Mozziconacci M, et al. High altitude pulmonary edema at moderate altitude (<2,400m; 7,870 feet): a series of 52 patients. Chest. 2003;123:49-53.

• 摘要

12.  Hackett PH, Roach RC. High altitude cerebral oedema. High Alt Med Biol. 2004;5:136-146.

• 摘要

13.  Wilson MH, Newman S, Imray CH. The cerebral effects of ascent to high altitudes. Lancet Neurol. 2009;8:175-191.

• 摘要

14.  Sanchez del Rio M, Moskowitz MA. High altitude headache: lessons from headaches at sea level. Adv Exp Med Biol. 1999;474:145-153.

• 摘要

15.  Bärtsch P, Bailey DM, Berger MM, Knauth M, et al. Acute mountain sickness: controversies and advances. High Alt Med Biol. 2004;5:110-124.

• 摘要

16.  Bärtsch P, Roach RC. Acute mountain sickness. In: Hornbein TF, Schoene RB, eds. High altitude: an exploration of human adaptation, vol 161. New York: Marcel Dekker; 2001:731-776.

17.  Jensen JB, Wright AD, Lassen NA, et al. Cerebral blood flow in acute mountain sickness. J Appl Physiol. 1990;69:430-433.

• 摘要

18.  Schoene RB. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol. 2004;5:125-135.

• 摘要

19.  Maggiorini M. High altitude-induced pulmonary edema. Cardiovasc Res. 2006;72:41-50.

• 摘要

20.  Dehnert C, Risse F, Ley S, et al. Magnetic resonance imaging of uneven pulmonary perfusion in hypoxia in humans. Am J Resp Crit Care Med. 2006;174:1132-1138.

• 摘要

21.  Hackett PH, Yarnell PR, Hill R, et al. High altitude cerebral edema evaluated with magnetic resonance imaging. JAMA. 1998;280:1920-1925.

• 摘要

22.  Sartori C, Lepori M, Maggiorini M, et al. Impairment of amiloride-sensitive sodium transport in individuals susceptible to HAPE. In: Roach RC, Wagner P, Hackett PH, eds. Hypoxia into the next millennium. New York: Kluwer Academic/Plenum; 1999:426.

23.  Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high altitude pulmonary edema. New Engl J Med. 2002;346:1631-1636.

• 摘要

24.  Hackett PH, Rennie D. The incidence, importance and prophylaxis of acute mountain sickness. Lancet. 1976;2:1149-1155.

• 摘要

25.  Singh I, Kapila C, Khanna P, et al. High altitude pulmonary edema. Lancet. 1965;1:229-234.

• 摘要

26.  Burtscher M, Brandstätter E, Gatterer H. Preacclimatization in simulated altitudes. Sleep Breath. 2008;12:109-114.

• 摘要

27.  Richalet J-P, Keromes A, Dersch B, et al. Caracteristiques physiologiques des alpinistes de haute altitude. Sci Sports. 1988;3:89-108.

28.  Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med. 2014;25(suppl):S4-S14.

• 全文
• 摘要

29.  Schneider M, Bernasch D, Weymann J, et al. Acute mountain sickness: influence of susceptibility, pre-exposure and ascent rate. Med Sci Sports Exerc. 2002;34:1886-1891.

• 摘要

30.  Ziaee V, Yunesian M, Ahmadinejad Z, et al. Acute mountain sickness in Iranian trekkers around Mt Damavand in Iran. Wilderness Environ Med. 2003;14:214-219.

• 摘要

31.  Graham J, Potyk D. Age and acute mountain sickness - examining the data. JAGS. 2005;53:735.

• 摘要

32.  Vearrier D, Greenberg MI. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance. Clin Toxicol (PA). 2011;49:629-640.

• 摘要

33.  Roach RC, Maes D, Sandoval D, et al. Exercise exacerbates acute mountain sickness at simulated altitude. J Appl Physiol. 2000;88:581-585.

• 全文
• 摘要

34.  Gaillard S, Dellasanta P, Lautan L, et al. Awareness, prevalence, medication use and risk factors of acute mountain sickness in tourists trekking around the Annapurna in Nepal: a 12 year follow-up. High Alt Med Biol. 2004;5:410-419.

• 摘要

35.  Basnyat B, Gertsch JH, Holck PS, et al. Acetazolamide 125mg BD is not significantly different from 37mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) TRIAL. High Alt Med Biol Spr. 2006;7:17-27.

• 摘要

36.  Dumont L, Mardirosoff C, Tramèr MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ. 2000;321:267-272.

• 全文
• 摘要

37.  Bärtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325:1284-1289.

• 全文
• 摘要

38.  Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008;9:265-269.

• 全文
• 摘要

39.  Maggiorini M, Bärtsch P, Oelz O.Association between raised body temperature and acute mountain sickness: cross sectional study. BMJ. 1997;315:403-404.

• 全文
• 摘要

40.  Bärtsch P, Shaw S, Franciolli M, et al. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol. 1988;65:1929-1937.

• 摘要

41.  Bircher HP, Eichenberger U, Maggiorini M, et al. Relationship of mountain sickness to physical fitness and exercise intensity during ascent. J Wilderness Med. 1994;5:302-311.

42.  Roach RC, Greene ER, Schoene RB, et al. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med. 1998;69:1182-1185.

• 摘要

43.  Schoene RB, Swenson ER, Hultgren HN. High altitude pulmonary edema. In: Hornbein TF, Schoene RB, eds. High altitude: an exploration of human adaptation. New York, NY: Marcel Dekker; 2001:777-814.

44.  Menon ND. High altitude pulmonary edema: a clinical study. New Engl J Med. 1965;273:66-73.

• 摘要

45.  Ward MP, Milledge JS, West JB. High altitude medicine and physiology. 3rd ed. London: Arnold; 2000.

46.  Vock P, Fretz C, Franciolli M, et al. High altitude pulmonary edema; findings at high altitude chest radiography and physical examination. Radiology. 1989;170:661-666.

• 摘要

47.  Fagenholz PJ, Gutman JA, Murray AF, et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt Med Biol. 2007;8:139-146.

• 摘要

48.  Marticorena E, Tapia FA, Dyer J, et al. Pulmonary edema by ascending to high altitudes. Dis Chest. 1964;45:273-283.

• 摘要

49.  Houston CS. Acute pulmonary edema of high altitude. New Engl J Med. 1960;263:478-480.

• 摘要

50.  Fagenholz PJ, Gutman JA, Murray AF, et al. Chest ultrasonography for the diagnosis and monitoring of high altitude pulmonary edema. Chest. 2007;131:1013-1018.

• 摘要

51.  Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high altitude pulmonary edema. JAMA. 2006;296:2954-2958.

• 全文
• 摘要

52.  Houston CS, Dickinson J. Cerebral form of high altitude illness. Lancet. 1975;2:758-761.

• 摘要

53.  Windsor JS, Rodway GW. Supplemental oxygen and sleep at high altitude. High Alt Med Biol. 2006;7:307-311.

• 摘要

54.  Hultgren H, Honigman B, Theis K, et al. High altitude pulmonary edema in a ski resort. West J Med. 1996;164:222-227.

• 摘要

55.  Cogo A, Fischer R, Schoene R. Respiratory disease and high altitude. High Alt Med Biol. 2004;5:435-444.

• 摘要

56.  Faulhaber M, Flatz M, Gatterer, et al. Prevalence of cardiovascular diseases among alpine skiers and hikers in the Austrian Alps. High Alt Med Biol. 2007;8:245-252.

• 摘要

57.  Lipman GS. Carbon monoxide toxicity at high altitude. Wilderness Environ Med. 2006;17:144-146.

• 摘要

58.  Ahmad H. Diabetic ketoacidosis in an undiagnosed diabetic precipitated by high altitude pulmonary edema. High Alt Med Biol. 2006;7:84-86.

• 摘要

59.  Speedy DB, Noakes TD, Rogers IR, et al. Hyponatraemia in ultradistance triathletes. Med Sci Sports Exerc. 1999;31:809-815.

• 摘要

60.  Schmidt W, Rojas J, Boning D, et al. Plasma electrolytes in natives to hypoxia after marathon races at different altitudes. Med Sci Sports Exerc. 1999;31:1406-1413.

• 摘要

61.  Baumgartner RW, Siegel AM, Hackett PH. Going high with preexisting neurological conditions. High Alt Med Biol. 2007;8:108-116.

• 摘要

62.  Barry PW, Pollard AJ. Altitude illness. BMJ. 2003;326:915-919.

• 全文
• 摘要

63.  Rock PB, Johnson TS, Larsen RF, et al. Dexamethasone as prophylaxis for acute mountain sickness. Effects of dose level. Chest. 1989;95:568-573.

• 摘要

64.  Subedi BH, Pokharel J, Goodman TL, et al. Complications of steroid use on Mt. Everest. Wilderness Environ Med. 2010;21:345-348.

• 摘要

65.  Low EV, Avery AJ, Gupta V, et al. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. BMJ. 2012;345:e6779.

• 全文
• 摘要

66.  Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide for the prevention of acute mountain sickness - a systematic review and meta-analysis. J Travel Med. 2012;19:298-307.

• 全文
• 摘要

67.  Seupaul RA, Welch JL, Malka ST, et al. Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. Ann Emerg Med. 2012;59:307-317.

• 摘要

68.  Ferrazzini G, Maggiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone. BMJ. 1987;294:1381-1383.

• 全文
• 摘要

69.  Wu TY, Ding SQ, Liu JL, et al. High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula. World J Gastroenterol. 2007;13:774-780.

• 摘要

70.  Burtscher M, Likar R, Nachbauer W, et al. Aspirin for prophylaxis against headache at high altitudes: randomized, double blind, placebo controlled trial. BMJ. 1998;316:1057-1058.

• 全文
• 摘要

71.  Grissom CK, Roach RC, Samquist FH, et al. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med. 1992;16:461-465.

• 摘要

72.  Wright AD, Winterborn MH, Forster PJ, et al. Carbonic anhydrase inhibition in the immediate therapy of acute mountain sickness. J Wilderness Med. 1994;5:49-55.

73.  Nerin MA, Palop J, Montano JA, et al. Acute mountain sickness: influence of fluid intake. Wilderness Environ Med. 2006;17:215-220.

• 摘要

74.  Keller HR, Maggiorini M, Bärtsch P, et al. Simulated descent vs dexamethasone in treatment of AMS - a randomized trial. BMJ. 1995;310:1232-1235.

• 全文
• 摘要

75.  Weil JV. Sleep at altitude. High Alt Med Biol. 2004;5:180-188.

• 摘要

76.  Beaumont M, Goldenberg F, Lejeune D, et al. Effect of zolpidem on sleep an ventilatory patterns at simulated altitude of 4000m. Am J Crit Care Med. 1996;153:1864-1869.

• 摘要

77.  Dubowitz G. Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomized placebo controlled crossover trial. BMJ. 1998;316:587-589.

• 全文
• 摘要

78.  Rodway GW, Windsor JS, Hart ND, Caudwell Xtreme Everest Research Group. Supplemental oxygen and hyperbaric treatment at high altitude: cardiac and respiratory response. Aviat Space Environ Med. 2007;78:613-617.

• 摘要

79.  Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary edema. Lancet. 1989;2:1241-1244.

• 摘要

80.  Ghofrani HA, Reichenberger F, Kohstall MG. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med. 2004;141:169-177.

• 摘要

81.  Richalet JP, Gratadour P, Robach P, et al. Sildenafil inhibits altitude-induced hypoxia and pulmonary hypertension. Am J Resp Crit Care. 2005;171:275-281.

• 全文
• 摘要

82.  Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high altitude pulmonary edema. Ann Int Med. 2006;145:497-506.

• 摘要

83.  van Patot MC, Keyes LE, Leadbetter G 3rd, et al. Ginkgo biloba for prevention of acute mountain sickness: does it work? High Alt Med Biol. 2009;10:33-43.

• 摘要